KYORIN Pharmaceutical Co., Ltd. - Your health is Kyorin's mission.

News Release

• January 18, 2010
  MARKETING APPROVAL FOR "MUCODYNE® DS50%"
• January 7, 2010
  Application filed for Orally Disintegrating Tablet of imidafenacin (INN), a Drug for Overactive Bladder
• November 5, 2009
  Execution of License Agreement on Neramexane for Tinnitus with Merz Pharmaceuticals for Japan Territory
• September 29, 2009
  KYORIN and Eisai Sign License Agreement for Development and Marketing of Uritos® Tablets in China, India, Sri Lanka and ASEAN Countries
• July 27, 2009
  Grant of Marketing Right to Senju Pharmaceutical on Gatifloxacin Ophthalmic Solution in China
• April 3, 2009
  Change of Representative Director and President at KYORIN Pharmaceutical

• News Release
• RSS